Can low ferritin from gastrointestinal malabsorption cause fatigue before anemia develops?

Iron deficiency is a progressive physiological state characterized by the depletion of systemic iron stores. Research confirms that this depletion can manifest as significant clinical symptoms, most notably fatigue, well before red blood cell production is impaired enough to cause anemia.

Diagnostic utility of serum ferritin

Serum ferritin serves as the primary and most specific biomarker for identifying absolute iron deficiency.

• Specificity and Sensitivity: Ferritin levels have an exceptionally high specificity (92% to 100%) for the absence of bone marrow iron stores. While its sensitivity varies (28% to 65%), a low reading is highly reliable for confirming deficiency.
• Thresholds: While the World Health Organization (WHO) traditionally uses a cut-off of <15 μg/L, modern clinical guidelines frequently advocate for higher thresholds, such as <30 μg/L or even <50 μg/L, to increase sensitivity for capturing iron deficiency without anemia (IDWA).
• Inflammatory Context: It is important to note that ferritin is an acute-phase reactant; in the presence of inflammation, levels may appear falsely elevated, requiring higher diagnostic cut-offs (e.g., <100 μg/L) or supplemental markers like transferrin saturation.

Malabsorption and iron transport

Gastrointestinal malabsorption is a major contributor to iron deficiency through the disruption of duodenal transport mechanisms.

• Mechanisms: Dietary iron is primarily absorbed in the duodenum via divalent metal transporter 1 (DMT1) and ferroportin. Conditions such as Celiac disease and Inflammatory Bowel Disease (IBD) cause mucosal damage that directly impairs these transporters.
• Clinical Impact: In Celiac disease, mucosal damage leads to iron deficiency anemia in approximately 14.6% of patients. Additionally, chronic inflammation in conditions like Crohn’s disease triggers the upregulation of hepcidin, which degrades ferroportin and blocks iron export from intestinal cells into the bloodstream.

Fatigue in non-anemic iron deficiency

Fatigue is frequently the presenting symptom of iron deficiency before any changes in hemoglobin are detected.

• Mitochondrial Mechanism: The fatigue associated with IDWA is driven by impaired mitochondrial energetics rather than reduced oxygen delivery. Iron is a critical cofactor for iron-sulfur (Fe-S) clusters in mitochondrial complex I. Depletion of these clusters reduces respiratory chain activity and ATP production, specifically in oxidative muscle tissues, leading to reduced endurance and easy fatigability.
• Intervention Evidence: Meta-analyses of randomized controlled trials demonstrate that iron supplementation significantly reduces subjective fatigue scores in non-anemic women, particularly those with ferritin levels ≤50 μg/L.

Bottom line

Low serum ferritin is a highly specific marker of iron deficiency, which often results from gastrointestinal malabsorption disrupting duodenal transport. This state frequently causes fatigue prior to the onset of anemia due to impaired mitochondrial energy production in muscle tissue.